ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 623

$653K Total Retail Price of All Prescriptions

Rank: 20 out of 623

425 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 425 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 425 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 8,302 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 341 288 1 4
LISINOPRIL 273 220 2 1
OMEPRAZOLE 269 191 3 7
SIMVASTATIN 268 236 4 2
SERTRALINE HCL 266 262 5 20
FUROSEMIDE 246 226 6 5
CITALOPRAM HBR 180 171 7 21
WARFARIN SODIUM 176 110 8 14
DONEPEZIL HCL 163 163 9 27
TRAMADOL HCL 154 124 10 15
AMLODIPINE BESYLATE 148 138 11 3
METOPROLOL TARTRATE 135 116 12 9
ALBUTEROL SULFATE 133 65 13 69
MIRTAZAPINE 133 129 13 31
LACTULOSE 114 64 15 67
RANITIDINE HCL 109 90 16 23
FLUTICASONE PROPIONATE 106 99 17 29
PRAVASTATIN SODIUM 106 89 17 11
SPIRIVA 101 87 19 58
NAMENDA 100 100 20 47
CARVEDILOL 99 93 21 32
LEVOFLOXACIN 98 85 22 72
ATENOLOL 98 85 22 12
ADVAIR DISKUS 97 84 24 39
GLIMEPIRIDE 94 81 25 38
CLOPIDOGREL 93 90 26 34
POTASSIUM CHLORIDE 91 88 27 24
METOPROLOL SUCCINATE 90 79 28 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 89 70 29 78
PREDNISONE 88 61 30 40
CARBIDOPA-LEVODOPA 87 86 31 88
OXYCODONE-ACETAMINOPHEN 86 41 S2 32 42
POLYETHYLENE GLYCOL 3350 85 67 33 53
QUETIAPINE FUMARATE 80 59 34 51
METFORMIN HCL 80 59 34 6
RISPERIDONE 78 78 36 49
IPRATROPIUM BROMIDE 75 21 37 133
GABAPENTIN 75 61 37 18
AZITHROMYCIN 70 63 39 45
ROPINIROLE HCL 69 65 40 111
PLAVIX 68 66 41 46
TAMSULOSIN HCL 66 58 42 35
CIPROFLOXACIN HCL 63 55 43 61
SEROQUEL 62 48 44 129
DIVALPROEX SODIUM 61 53 45 77
PANTOPRAZOLE SODIUM 60 53 46 26
PAROXETINE HCL 59 37 47 66
TRAZODONE HCL 57 50 48 36
OLANZAPINE 56 56 49 120
ACETYLCYSTEINE 56 0 49 266
ENOXAPARIN SODIUM 54 21 51 162
LANSOPRAZOLE 54 53 51 147
IPRATROPIUM-ALBUTEROL 53 0 53 91
SPIRONOLACTONE 53 41 53 101
LANTUS 52 44 55 41
OXYBUTYNIN CHLORIDE 51 42 56 134
ATORVASTATIN CALCIUM 51 43 56 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.